메뉴 건너뛰기




Volumn 9, Issue 2, 2012, Pages 91-100

Atrial fibrillation in the elderly

Author keywords

Atrial fibrillation; Heart failure; Prevention; Thrombo embolism; Treatment

Indexed keywords

ALDOSTERONE ANTAGONIST; AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; APIXABAN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BLOOD CLOTTING FACTOR 10A INHIBITOR; DIGITALIS; DIGOXIN; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DRONEDARONE; ESMOLOL; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METOPROLOL; OMEGA 3 FATTY ACID; PROPAFENONE; PROPRANOLOL; SOTALOL; THROMBIN INHIBITOR; VERAPAMIL; WARFARIN;

EID: 84866252290     PISSN: 16715411     EISSN: None     Source Type: Journal    
DOI: 10.3724/SP.J.1263.2011.12293     Document Type: Conference Paper
Times cited : (13)

References (70)
  • 1
    • 0029321109 scopus 로고
    • From delirium cordis to atrial fibrillation: Historical development of a disease concept
    • Flegel KM. From delirium cordis to atrial fibrillation: historical development of a disease concept. Ann Intern Med 1995; 122: 867-873.
    • (1995) Ann Intern Med , vol.122 , pp. 867-873
    • Flegel, K.M.1
  • 2
    • 77952241518 scopus 로고    scopus 로고
    • The genetics of atrial fibrillation
    • Sabeh MK, MacRae CA. The genetics of atrial fibrillation. Curr Opin Cardiol 2010, 25: 186-191.
    • (2010) Curr Opin Cardiol , vol.25 , pp. 186-191
    • Sabeh, M.K.1    MacRae, C.A.2
  • 3
    • 0035810152 scopus 로고    scopus 로고
    • Atrial fibrillation
    • DOI 10.1056/NEJM200104053441407
    • Falk RH. Atrial fibrillation. N Engl J Med 2001; 344: 1067-1078. (Pubitemid 32267978)
    • (2001) New England Journal of Medicine , vol.344 , Issue.14 , pp. 1067-1078
    • Falk, R.H.1
  • 4
    • 0035832261 scopus 로고    scopus 로고
    • Prevalence of diagnosed atrial fibrillation in Adults
    • Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in Adults JAMA 2001; 285: 2370-2375.
    • (2001) JAMA , vol.285 , pp. 2370-2375
    • Go, A.S.1    Hylek, E.M.2    Phillips, K.A.3
  • 5
    • 0028299731 scopus 로고
    • Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study
    • Benjamin EJ, Levy D, Vaziri SM, et al. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA 1994; 271: 840-844.
    • (1994) JAMA , vol.271 , pp. 840-844
    • Benjamin, E.J.1    Levy, D.2    Vaziri, S.M.3
  • 6
    • 77957750990 scopus 로고    scopus 로고
    • Annual incidence of atrial fibrillation and related factors in adults
    • Iguchi Y, Kimura K, Shibazaki K, et al. Annual incidence of atrial fibrillation and related factors in adults. Am J Cardiol 2010; 106: 1129-1133.
    • (2010) Am J Cardiol , vol.106 , pp. 1129-1133
    • Iguchi, Y.1    Kimura, K.2    Shibazaki, K.3
  • 8
    • 4744358589 scopus 로고    scopus 로고
    • Diretriz de Fibrilação Atrial da Sociedade Brasileira de Cardiologia
    • Diretriz de Fibrilação Atrial da Sociedade Brasileira de Cardiologia. Arq Bras Cardiol 2003; 81 (Supl VI): S1-S24.
    • (2003) Arq Bras Cardiol , vol.81 , Issue.SUPPL. VI
  • 9
    • 0000761593 scopus 로고    scopus 로고
    • ACC/AHA/ESC Guidelines for the management of patients with atrial fibrillation
    • Fuster A, Rydén LE, Asinger RW, et al. ACC/AHA/ESC Guidelines for the management of patients with atrial fibrillation. J Am Coll Cardiol 2001; 38: 1266.
    • (2001) J Am Coll Cardiol , vol.38 , pp. 1266
    • Fuster, A.1    Rydén, L.E.2    Asinger, R.W.3
  • 10
    • 74249103558 scopus 로고    scopus 로고
    • Persistent atrial fibrillation: Current approach and controversies
    • Parkash R, Verma A, Tang ASL. Persistent atrial fibrillation: current approach and controversies. Curr Opin Cardiol 2010; 25: 1-7.
    • (2010) Curr Opin Cardiol , vol.25 , pp. 1-7
    • Parkash, R.1    Verma, A.2    Tang, A.S.L.3
  • 11
    • 0026785561 scopus 로고
    • Effect of Enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions
    • The SOLVD investigators
    • The SOLVD investigators. Effect of Enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992; 327: 685-691.
    • (1992) N Engl J Med , vol.327 , pp. 685-691
  • 12
    • 0027229344 scopus 로고
    • The influence of atrial fibrillation on prognosis in mild to moderate heart failure: The V-HeFT studies
    • Carson PE, Johnson GR, Dunkman WB, et al. The influence of atrial fibrillation on prognosis in mild to moderate heart failure. The V-heft Studies. The V-heft VA Cooperative Studies Group. Circulation 1993; 87: (6 Suppl): VI102-VI110. (Pubitemid 23164229)
    • (1993) Circulation , vol.87 , Issue.6 SUPPL. VI
    • Carson, P.E.1    Johnson, G.R.2    Dunkman, W.B.3    Fletcher, R.D.4    Farrell, L.5    Cohn, J.N.6
  • 13
    • 0021187418 scopus 로고
    • Thyrotoxicosis in institutionalized elderly patients with atrial fibrillation
    • DOI 10.1001/archinte.144.9.1758
    • Cobler JL, Williams ME, Greenland P. Thyrotoxicosis in institutionalized elderly Patients with Atrial Fibrillation. Arch Intern Med 1984; 144: 1758-1760. (Pubitemid 14070028)
    • (1984) Archives of Internal Medicine , vol.144 , Issue.9 , pp. 1758-1760
    • Cobler, J.L.1    Williams, M.E.2    Greenland, P.3
  • 16
    • 0030716498 scopus 로고    scopus 로고
    • Shattuck lecture cardiovascular medicine at the turn of the millennium: Triumphs, concerns, and opportunities
    • DOI 10.1056/NEJM199711063371906
    • Braunwald E. Shattuck lecture: Cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N Engl J Med 1997; 337: 1360-1369. (Pubitemid 27467771)
    • (1997) New England Journal of Medicine , vol.337 , Issue.19 , pp. 1360-1369
    • Braunwald, E.1
  • 18
    • 0016719516 scopus 로고
    • Left atrial transport function in myocardial infarction. Importance of its booster pump function
    • Rahimtoola SH, Ehsani A, Sinno MZ, et al. Left atrial transport function in myocardial infarction. Importance of its booster pump function. Am J Med 1975; 59: 686-694.
    • (1975) Am J Med , vol.59 , pp. 686-694
    • Rahimtoola, S.H.1    Ehsani, A.2    Sinno, M.Z.3
  • 20
    • 0026785561 scopus 로고
    • The solvd investigators studies of left ventricular disfunction effect of enalapril on mortality and the development of heart failure in assymptomatic patientes with reduced left ventricular ejection fraction
    • The solvd investigators studies of left ventricular disfunction effect of enalapril on mortality and the development of heart failure in assymptomatic patientes with reduced left ventricular ejection fraction. N Engl J Med 1992; 327: 685-691.
    • (1992) N Engl J Med , vol.327 , pp. 685-691
  • 21
    • 0025779484 scopus 로고
    • Atrial fibrillation as an independent risk factor for stoke. The framingham study
    • Wolf PA, Abbot RD, Kannel WB. Atrial fibrillation as an independent risk factor for stoke. The framingham study. Stroke 1991; 22: 983-988.
    • (1991) Stroke , vol.22 , pp. 983-988
    • Wolf, P.A.1    Abbot, R.D.2    Kannel, W.B.3
  • 22
    • 0026543430 scopus 로고
    • Predictors of thromboembolism in atrial fibrillation: I. Clinical features of patients at risk. The stroke prevention in atrial fibrillation investigators
    • Predictors of thromboembolism in atrial fibrillation: I. Clinical features of patients at risk. The stroke prevention in atrial fibrillation investigators. Ann Intern Med 1992; 116: 1-5.
    • (1992) Ann Intern Med , vol.116 , pp. 1-5
  • 23
    • 0001183687 scopus 로고    scopus 로고
    • Transesophageal echocardiography to asses embolic risk in patients with atrial fibrillation
    • Stollberger C, Chnupa P, Kronik G, et al. Transesophageal echocardiography to asses embolic risk in patients with atrial fibrillation. Ann Intern Med 1998; 128: 630-638.
    • (1998) Ann Intern Med , vol.128 , pp. 630-638
    • Stollberger, C.1    Chnupa, P.2    Kronik, G.3
  • 25
    • 76749163232 scopus 로고    scopus 로고
    • Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: The euro heart survey on atrial fibrillation
    • Lip GY, Nieuwlaat R, Pisters R, et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 2010; 137: 263-272.
    • (2010) Chest , vol.137 , pp. 263-272
    • Lip, G.Y.1    Nieuwlaat, R.2    Pisters, R.3
  • 26
    • 65649145705 scopus 로고    scopus 로고
    • Effect of clopidogrel added to aspirin in patients with atrial fibrillation
    • ACTIVE investigators
    • ACTIVE investigators. Effect of clopidogrel added to aspirin in patients with atrial fibrillation. N Eng J Med 2009; 360: 2066-2078.
    • (2009) N Eng J Med , vol.360 , pp. 2066-2078
  • 27
    • 44449091140 scopus 로고    scopus 로고
    • Risks and benefits of oral anticoagulation compared with clopidogrel plus aspirin in patients with atrial fibrillation according to stroke risk
    • Healey J, Hart RG, Pogue J, et al. Risks and benefits of oral anticoagulation compared with clopidogrel plus aspirin in patients with atrial fibrillation according to stroke risk. Stroke 2008; 39: 1482-1486.
    • (2008) Stroke , vol.39 , pp. 1482-1486
    • Healey, J.1    Hart, R.G.2    Pogue, J.3
  • 29
    • 50849089302 scopus 로고    scopus 로고
    • Atrial fibrillation in stroke free patients is associated with memory impairment and hippocampal atrophy
    • Knecht S, Oelschlager C, Duning T, et al. Atrial fibrillation in stroke free patients is associated with memory impairment and hippocampal atrophy. Eur Heart J 2008; 29: 2125-2132.
    • (2008) Eur Heart J , vol.29 , pp. 2125-2132
    • Knecht, S.1    Oelschlager, C.2    Duning, T.3
  • 31
    • 0347228969 scopus 로고    scopus 로고
    • Long-Term Risk of Recurrent Atrial Fibrillation as Documented by an Implantable Monitoring Device: Implications for Optimal Patient Care
    • DOI 10.1016/j.jacc.2003.08.027
    • Israel CW, Gronefeld G, Ehrlich JR, et al. Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device: Implications for optimal patient care. J Am Coll Cardiol 2004; 43: 47-52. (Pubitemid 38045914)
    • (2004) Journal of the American College of Cardiology , vol.43 , Issue.1 , pp. 47-52
    • Israel, C.W.1    Gronefeld, G.2    Ehrlich, J.R.3    Li, Y.-G.4    Hohnloser, S.H.5
  • 33
    • 0037418332 scopus 로고    scopus 로고
    • Asymptomatic or "Silent"atrial fibrillation. frequency in untreated patients and patients receiving azimilide
    • Page RL, Tilsch TW, Conolly SJ, et al. Asymptomatic or "Silent"atrial fibrillation. frequency in untreated patients and patients receiving azimilide. Circulation 2003; 107: 1041-1045.
    • (2003) Circulation , vol.107 , pp. 1041-1045
    • Page, R.L.1    Tilsch, T.W.2    Conolly, S.J.3
  • 34
    • 0030659070 scopus 로고    scopus 로고
    • Thromboembolism in chronic atrial flutter: Is the risk underestimated?
    • DOI 10.1016/S0735-1097(97)00326-4, PII S0735109797003264
    • Lanzarotti CJ, Olshansky B. Thromboembolism in chronis atrial flutter: Is the risk underestimated. J Am Coll Cardiol 1997; 30: 1506-1511. (Pubitemid 27486469)
    • (1997) Journal of the American College of Cardiology , vol.30 , Issue.6 , pp. 1506-1511
    • Lanzarotti, C.J.1    Olshansky, B.2
  • 36
    • 9244247612 scopus 로고    scopus 로고
    • Obesity and the risk of new-onset atrial fibrillation
    • Thomas WJ, Helen P, Daniel L, et al. Obesity and the risk of new-onset atrial fibrillation. JAMA 2004; 292: 2471-2477.
    • (2004) JAMA , vol.292 , pp. 2471-2477
    • Thomas, W.J.1    Helen, P.2    Daniel, L.3
  • 37
    • 0025084193 scopus 로고
    • Assessment of cardiac function in patients who were morbidly obese
    • Alaud-din A, Meterissian S, Lisbona R, et al. Assessment of cardiac function in patients who were morbidly obese. Surgery 1990; 108: 809-818.
    • (1990) Surgery , vol.108 , pp. 809-818
    • Alaud-din, A.1    Meterissian, S.2    Lisbona, R.3
  • 40
    • 0036735143 scopus 로고    scopus 로고
    • Association of the human mink gene 38G allele with atrial fibrillation: Evidence of possible genetic control on the pathogenesis of atrial fibrillation
    • Lai LP, Su MJ, Yeh HM, et al. Association of the human mink gene 38G allele with atrial fibrillation: evidence of possible genetic control on the pathogenesis of atrial fibrillation. Am Heart J 2002; 144: 485-490.
    • (2002) Am Heart J , vol.144 , pp. 485-490
    • Lai, L.P.1    Su, M.J.2    Yeh, H.M.3
  • 41
    • 0033527355 scopus 로고    scopus 로고
    • Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: A meta-analysis
    • Hart RG, Benavente O, McBride R, et al. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Ann Intern Med 1999; 131: 492-501. (Pubitemid 29482392)
    • (1999) Annals of Internal Medicine , vol.131 , Issue.7 , pp. 492-501
    • Hart, R.G.1    Benavente, O.2    McBride, R.3    Pearce, L.A.4
  • 42
    • 34347394385 scopus 로고    scopus 로고
    • Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation
    • Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 2007; 146: 857-867. (Pubitemid 351650486)
    • (2007) Annals of Internal Medicine , vol.146 , Issue.12 , pp. 857-867
    • Hart, R.G.1    Pearce, L.A.2    Aguilar, M.I.3
  • 43
    • 1842434297 scopus 로고    scopus 로고
    • Relationships between sinus rhythm, treatment, and survival in the AFFIRM study
    • Corley SD, Epstein AE, DiMarco JP, et al. Relationships between sinus rhythm, treatment, and survival in the AFFIRM study. Circulation 2004; 109: 1509-1513.
    • (2004) Circulation , vol.109 , pp. 1509-1513
    • Corley, S.D.1    Epstein, A.E.2    DiMarco, J.P.3
  • 44
    • 36248994010 scopus 로고    scopus 로고
    • Incidence of Stroke in Paroxysmal Versus Sustained Atrial Fibrillation in Patients Taking Oral Anticoagulation or Combined Antiplatelet Therapy. An ACTIVE W Substudy
    • DOI 10.1016/j.jacc.2007.07.076, PII S0735109707028525
    • Hohnloser SH, Pajitnev D, Pogue J, et al. Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy. J Am Coll Cardiol 2007; 50: 2156-2161. (Pubitemid 350123679)
    • (2007) Journal of the American College of Cardiology , vol.50 , Issue.22 , pp. 2156-2161
    • Hohnloser, S.H.1    Pajitnev, D.2    Pogue, J.3    Healey, J.S.4    Pfeffer, M.A.5    Yusuf, S.6    Connolly, S.J.7
  • 45
    • 0035128599 scopus 로고    scopus 로고
    • Antithrmbotic therapy in atrial fibrillation
    • Albers GW, Dalen JE, Laupacis A, et al. Antithrmbotic therapy in atrial fibrillation. Chest 2001; ll9(Suppl 1): 194S.
    • (2001) Chest , vol.9 , Issue.SUPPL. 1
    • Albers, G.W.1    Dalen, J.E.2    Laupacis, A.3
  • 46
    • 0029741822 scopus 로고    scopus 로고
    • An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation
    • DOI 10.1056/NEJM199608223350802
    • Hylek EM, Skates SJ, Sheehan MA, et al. An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with non-rheumatic atrial fibrillation. N Engl J Med 1996; 335: 540-546. (Pubitemid 26272308)
    • (1996) New England Journal of Medicine , vol.335 , Issue.8 , pp. 540-546
    • Hylek, E.M.1    Skates, S.J.2    Sheehan, M.A.3    Singer, D.E.4
  • 48
    • 77955872745 scopus 로고    scopus 로고
    • A novel user- Friendly score (HAS-BLED) to assess one-year risk of major bleeding in atrial fibrillation patients: The Euro Heart Survey
    • Pisters R, Lane DA, Nieuwelaat R, et al. A novel user- friendly score (HAS-BLED) to assess one-year risk of major bleeding in atrial fibrillation patients: the Euro Heart Survey. Chest 2010; 138: 1093-1100.
    • (2010) Chest , vol.138 , pp. 1093-1100
    • Pisters, R.1    Lane, D.A.2    Nieuwelaat, R.3
  • 49
    • 80052094564 scopus 로고    scopus 로고
    • A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anti-coagulation and Risk Factors in Atrial Fibrillation) Study
    • Fang MC, Go AS, Chang Y, et al. A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anti-coagulation and Risk Factors in Atrial Fibrillation) Study. J Am Coll Cardiol 2011; 58: 395-401.
    • (2011) J Am Coll Cardiol , vol.58 , pp. 395-401
    • Fang, M.C.1    Go, A.S.2    Chang, Y.3
  • 50
    • 77953019736 scopus 로고    scopus 로고
    • New pharmacotherapy for stroke prevention in atrial fibrillation
    • Armaganijan L, Eikelboom J, Healey JS, et al. New pharmacotherapy for stroke prevention in atrial fibrillation. Adv Ther 2009; 26: 1058-1071.
    • (2009) Adv Ther , vol.26 , pp. 1058-1071
    • Armaganijan, L.1    Eikelboom, J.2    Healey, J.S.3
  • 51
    • 79952445042 scopus 로고    scopus 로고
    • Recommendation for emerging antithrombotic agents 2011 focused update recommendation comments
    • Wann S, Curtis AB, Ellenbogen KA, et al, Recommendation for emerging antithrombotic agents 2011 focused update recommendation comments. J Am Coll Cardiol 2011; 57; 1330-1337.
    • (2011) J Am Coll Cardiol , vol.57 , pp. 1330-1337
    • Wann, S.1    Curtis, A.B.2    Ellenbogen, K.A.3
  • 52
    • 78649508381 scopus 로고    scopus 로고
    • Factors affecting adherence to guidelines for antithrombotic therapy in elderly patients with atrial fibrillation admitted to internal medicine wards
    • Marcucci M, Iorio A, Nobili A, et al. Factors affecting adherence to guidelines for antithrombotic therapy in elderly patients with atrial fibrillation admitted to internal medicine wards. Eur J Inten Med 2010; 21: 516-523.
    • (2010) Eur J Inten Med , vol.21 , pp. 516-523
    • Marcucci, M.1    Iorio, A.2    Nobili, A.3
  • 53
    • 0037456920 scopus 로고    scopus 로고
    • Risks and benefits of rate control versus maintenance of sinus rhythm
    • DOI 10.1016/S0002-9149(02)03376-3
    • Saxonhouse SJ, Curtis AB. Risks and benefits of rate control versus maintenance of sinus rhythm. Am J Cardiol 2003; 91: 27D-32D. (Pubitemid 36369331)
    • (2003) American Journal of Cardiology , vol.91 , Issue.6 SUPPL. 1
    • Saxonhouse, S.J.1    Curtis, A.B.2
  • 56
    • 1842434297 scopus 로고    scopus 로고
    • Relationships between sinus rhythm, treatment, and survival in the atrial fibrillation follow-up investigation of rhythm management (AFFIRM) study
    • The AFFIRM investigators
    • The AFFIRM investigators. Relationships between sinus rhythm, treatment, and survival in the atrial fibrillation follow-up investigation of rhythm management (AFFIRM) study. Circulation 2004; 109: 1509-1513.
    • (2004) Circulation , vol.109 , pp. 1509-1513
  • 57
    • 79955555879 scopus 로고    scopus 로고
    • Sociedade brasileira de cardiologia. diretrizes brasileiras de fibrilação atrial
    • Zimerman LI, Fenelon G, Martinelli Filho M, et al. Sociedade brasileira de cardiologia. diretrizes brasileiras de fibrilação atrial. Arq Bras Cardiol 2009; 92(6 Supl.1): S1-S39.
    • (2009) Arq Bras Cardiol , vol.92 , Issue.6 SUPPL.1
    • Zimerman, L.I.1    Fenelon, G.2    Martinelli Filho, M.3
  • 58
    • 74249117312 scopus 로고    scopus 로고
    • Dronedarone: A novel antiarrhythmic agent for the treatment of atrial fibrillation
    • Duray GZ, Ehrlich JR, Hohnloser SH. Dronedarone: A novel antiarrhythmic agent for the treatment of atrial fibrillation. Curr Opin Cardiol 2010, 25: 53-58.
    • (2010) Curr Opin Cardiol , vol.25 , pp. 53-58
    • Duray, G.Z.1    Ehrlich, J.R.2    Hohnloser, S.H.3
  • 61
    • 60549097431 scopus 로고    scopus 로고
    • Effect of dronedarone on cardiovascular events in atrial fibrillation
    • Hohnloser SH, Crijns HJ, van Eickels M, et al. Effect of dronedarone on cardiovascular events in atrial fibrillation. N Eng J Med 2009; 360: 668-678.
    • (2009) N Eng J Med , vol.360 , pp. 668-678
    • Hohnloser, S.H.1    Crijns, H.J.2    Van Eickels, M.3
  • 63
    • 79952217693 scopus 로고    scopus 로고
    • Upstream therapies for management of atrial fibrillation: Review of clinical evidence and implications for European Society of Cardiology Guidelines. Part I: Primary prevention
    • Savelieva I, Kakouros N, Kourliouros A, et al. Upstream therapies for management of atrial fibrillation: Review of clinical evidence and implications for European Society of Cardiology Guidelines. Part I: Primary prevention. Europace 2011; 13: 308-328.
    • (2011) Europace , vol.13 , pp. 308-328
    • Savelieva, I.1    Kakouros, N.2    Kourliouros, A.3
  • 64
    • 79953038399 scopus 로고    scopus 로고
    • 2011 ACCF/AHA/ HRS Focused Update incorporated into the ACC/AHA/ESC 2006 Guidelines for Management of Patients with Atrial Fibrillation (Updating the 2006 Guideline) A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
    • Fuster V, Ryden LE, Cannom DS, et al. 2011 ACCF/AHA/ HRS Focused Update incorporated into the ACC/AHA/ESC 2006 Guidelines for Management of Patients With Atrial Fibrillation (Updating the 2006 Guideline) A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2011; 123: E269-E367.
    • (2011) Circulation , vol.123
    • Fuster, V.1    Ryden, L.E.2    Cannom, D.S.3
  • 65
    • 77957738116 scopus 로고    scopus 로고
    • Guidelines for the management of atrial fibrillation the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC)
    • Camm JA, Kirchhof P, Lip GYH. et al. Guidelines for the management of atrial fibrillation the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Europace 2010; 12: 1360-1420.
    • (2010) Europace , vol.12 , pp. 1360-1420
    • Camm, J.A.1    Kirchhof, P.2    Lip, G.Y.H.3
  • 67
    • 41549133563 scopus 로고    scopus 로고
    • Catheter ablation vs antiarrhythmic drug therapy for atrial fibrillation: A systematic review
    • DOI 10.1001/archinte.168.6.581
    • Noheria A, Kumar A, Wylie JV Jr, et al. Catheter ablation vs antiarrhythmic drug therapy for atrial fibrillation: a systematic review. Arch Intern Med 2008; 168: 581-586. (Pubitemid 351468392)
    • (2008) Archives of Internal Medicine , vol.168 , Issue.6 , pp. 581-586
    • Noheria, A.1    Kumar, A.2    Wylie Jr., J.V.3    Josephson, M.E.4
  • 68
    • 77956410762 scopus 로고    scopus 로고
    • New Approaches to Atrial Fibrillation Management: Treat the Patient, not the ECG
    • Pinter A, Dorian P. New Approaches to Atrial Fibrillation Management: Treat the Patient, not the ECG. Cardiovasc Ther 2010; 5: 302-310.
    • (2010) Cardiovasc Ther , vol.5 , pp. 302-310
    • Pinter, A.1    Dorian, P.2
  • 69
    • 79955555879 scopus 로고    scopus 로고
    • Diretrizes brasileiras de fibrilação atrial
    • Zimerman LI., Fenelon G, Filho MM, et al. Diretrizes brasileiras de fibrilação atrial. Arq Bras Cardiol 2009; 92(6 Supl 1): S1-S39.
    • (2009) Arq Bras Cardiol , vol.92 , Issue.6 SUPPL. 1
    • Zimerman, L.I.1    Fenelon, G.2    Filho, M.M.3
  • 70
    • 79952045911 scopus 로고    scopus 로고
    • Sociedade brasileira de cardiologia. II diretrizes brasileiras em cardiogeriatria
    • Gravina CF, Rosa RF, Franken RA, et al. Sociedade brasileira de cardiologia. II diretrizes brasileiras em cardiogeriatria. Arq Bras Cardiol 2010; 95(3 Supl. 2): S1-S112.
    • (2010) Arq Bras Cardiol , vol.95 , Issue.3 SUPPL. 2
    • Gravina, C.F.1    Rosa, R.F.2    Franken, R.A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.